Creating advanced protein tools to control biological processes
Engineering Smart Antibody-like Protein Scaffolds with precision switches
This study is exploring new ways to create special proteins that can be controlled with light or medicine, which could help scientists better understand and treat conditions like Alzheimer's disease.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10902004 on NIH RePORTER |
What this research studies
This research focuses on developing innovative protein scaffolds that can be precisely controlled using light or drugs. By engineering these smart antibody-like proteins, the team aims to manipulate cellular functions and proteins in living organisms more effectively. This approach seeks to overcome limitations of existing methods that require extensive prior knowledge and can be slow or irreversible. Patients may benefit from advancements in treatments for conditions like Alzheimer's disease through improved understanding and control of biological pathways.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with Alzheimer's disease or related neurodegenerative conditions.
Not a fit: Patients with conditions unrelated to protein regulation or those who do not have neurodegenerative diseases may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that more effectively target and treat diseases like Alzheimer's by enhancing our ability to control biological processes.
How similar studies have performed: While the approach of using smart protein scaffolds is innovative, similar methodologies in chemogenetics and optogenetics have shown promise in other research areas, indicating potential for success.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Zhou, Yubin — Texas A&m University Health Science Ctr
- Study coordinator: Zhou, Yubin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.